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Kristaps Jaudzems 1,5,*
1 Department of Physical Organic Chemistry, Latvian Institute of Organic Synthesis, Aizkraukles 21,
LV-1006 Riga, Latvia; fridmanis.jekabs@osi.lv (J.F.); raitis.bobrovs@osi.lv (R.B.)
2 Latvian Biomedical Research and Study Centre, Ratsupites 1, LV-1067 Riga, Latvia;
kalvis@biomed.lu.lv (K.B.); kaspars@biomed.lu.lv (K.T.)
3 Department of Human Physiology and Biochemistry, Riga Stradins University, Dzirciema 16,
LV-1007 Riga, Latvia
4 Department of Molecular Biology, University of Latvia, Jelgavas 1, LV-1004 Riga, Latvia
5 Department of Organic Chemistry, University of Latvia, Jelgavas 1, LV-1004 Riga, Latvia
* Correspondence: kristaps.jaudzems@osi.lv; Tel.: +371 67014817
Received: 11 September 2020; Accepted: 7 October 2020; Published: 9 October 2020


Abstract: BBA03 is a Borrelia burgdorferi outer surface lipoprotein encoded on one of the most
conserved plasmids in Borrelia genome, linear plasmid 54 (lp54). Although many of its genes have
been identified as contributing or essential for spirochete fitness in vivo, the majority of the proteins
encoded on this plasmid have no known function and lack homologs in other organisms. In this
paper, we report the solution NMR structure of the B. burgdorferi outer surface lipoprotein BBA03,
which is known to provide a competitive advantage to the bacteria during the transmission from tick
vector to mammalian host. BBA03 shows structural homology to other outer surface lipoproteins
reflecting their genetic and evolutionary relatedness. Analysis of the structure reveals a pore in
BBA03, which could potentially bind lipids.
Keywords: BBA03; Pfam54; competitive advantage; lp54; solution NMR structure
1. Introduction
Lyme disease is the most widespread arthropod-transmitted disease in North America and
Europe [1]. It is caused by Borrelia burgdorferi sensu lato complex spirochetes, which are transferred
to a mammalian host through a bite of an infected tick [2]. If the infection is diagnosed at an early
stage, 14 day oral antibiotic treatment is sufficient to cure Lyme disease. If not treated or treated
inadequately, it can spread to major organs within the host, resulting in severe skin, joint, or neurological
problems [3,4].
One of the most highly conserved plasmids in the segmented Borrelia burgdorferi genome is lp54 [5].
Several of its encoded proteins such as OspA that is required for persistence within the tick and DbpA/B
decorin binding proteins that are important for dissemination in the mammal have been identified
as essential for spirochete survival in vivo [6,7]. Others such as BBA52, BBA64, and BBA03 play a
significant role in the transmission from tick to mammals, but their specific function has not been
identified thus far [8–10]. The expression of BBA03 increases six times during the tick blood meal and
decreases only two-fold from its initial value one week after the infection. Incubation of whole bacteria
in presence of proteinase K does not result in degradation of BBA03, whereas immunofluorescence
data indicate that it is at least partially surface exposed [8]. BBA03 deletion mutant, although fully
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competent by itself, cannot infect mice when transmitted by ticks that were simultaneously coinfected
with wild-type B. burgdorferi. The competitive advantage of BBA03 is absent in case the bacteria are
inoculated with a syringe. Lack of BBA03 also does not affect migration of Borrelia from tick midgut to
salivary glands. This implies a role for BBA03 in transition from tick salivary glands to the mammalian
host, suggesting it as a potential target for vaccine development. However, mice immunized with
BBA03 showed only minor protection against B. burgdorferi infection by a tick bite [8].
Here, we report the solution NMR structure of BBA03 from B. burgdorferi B31 strain. Structural
analysis and the known function of its identified structural homologs suggest that BBA03 may function
as a lipid binding protein.
2. Results
2.1. BBA03 Structure Determination
Uniformly 13C,15N-labeled BBA0323–169 protein was expressed in Escherichia coli BL21(DE)3
strain and purified to apparent homogeneity as described in Materials and Methods Section 4.1.
Its monomeric state was confirmed by NMR 15N spin-lattice (T1) and spin-spin (T2) relaxation
experiments (Supplementary Figure S1). Chemical shift assignments for the backbone and the 13Cβ
atoms were obtained through analysis of conventional 3D triple-resonance NMR spectra, while amino
acid side chains were assigned using 3D 15N- and 13C-resolved nuclear Overhauser enhancement
(NOE) spectra. This procedure allowed obtaining virtually complete chemical shift assignments
(99.8% for the backbone nuclei HN, 15N, 13Cα, Hα and 98.9% for non-labile sidechain hydrogens)
(see Supplementary Figure S2 for assigned 2D 15N-1H heteronuclear single-quantum correlation
(HSQC) spectrum). Analysis of 13Cα,β chemical shift deviations from random coil values showed that
29 N-terminal residues of BBA03 following the signal peptide are disordered (Figure 1a). To obtain
higher NMR spectral quality, the unstructured region was omitted from the expression plasmid,
and the truncated protein BBA0353–169 was used for structure determination. Structure calculation
based on NOE distance constraints then resulted in a well-defined structure (structural statistics are
given in Table 1).
2.2. Structure Analysis
The NMR structure shows that the folded part of BBA03 comprises 115 residues and forms a
seven-helix bundle (Figure 1b,c). Analysis of the structure using CASTp software [12] resulted in
identification of two clefts with solvent accessible volume larger than 20 Å3 (Figure 1c–e). Mole 2.5 [11]
online server found that clefts 1 and 2 form entrance to a 17.7 Å long T-shaped hydrophobic pore
(Figure 1c). Both clefts are positively charged. The hydrophobic nature of the pore and the positive
charge at its entrances suggests that it may bind lipids.
To investigate the possible binding of lipids to the hydrophobic pore of BBA03, we performed
molecular docking experiments (Figure 2a,b). Overall, presence of double bonds and increased fatty
acid chain length positively affected the ligand binding efficiency calculated as docking score divided
by heavy atom count. Four fatty acids (arachidonic acid, arachidic acid, linoleic acid, and oleic acid)
showed notably higher ligand efficiency scores as compared to others and formed polar contacts with
either R60 or N76 side chains.
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Figure 1. Structure of BBA03. (a) Secondary chemical shift analysis of BBA03. Here, Δδi is calculated 
as (ΔCα - ΔCβ) + (ΔCα − 1 - ΔCβ − 1) + (ΔCα + 1 - ΔCβ + 1) / 3. Δδi values above 1 for three or more consecutive 
residues are indicative of alpha helix (black) and below −1 of beta sheet secondary structure, whereas 
Δδi values between −1 and 1 indicate non-regular structure (white). (b,c) Cartoon representation of 
BBA03 structure colored using rainbow color scheme. It starts with blue color at N-terminus and 
gradually changes to red at C-terminus. In (c), the T-shaped pore identified by Mole 2.5 [11] online 
tool is shown in cyan. Clefts 1 and 2 found by CASTp software [12], larger than 20 Å 3, are denoted 
with numbers. The volume of the first cleft is 20.4 Å 3 and of the second is – 76.8 Å 3. (d,e) Electrostatic 
potential of BBA03 surface, calculated using Adaptive Poisson-Boltzmann Solver (APBS) Pymol 
plugin [13]. The gradient starts from red, where 5 kBT/e < 4, and moves to deep blue, where 5 kBT/e 
> 4. Above mentioned clefts are marked with a dashed line.  
Figure 1. Structure of BBA03. (a) Secondary chemical shift analysis of BBA03. Here, ∆δi is calculated
as (∆Cα - ∆Cβ) + (∆Cα − 1 - ∆Cβ − 1) + (∆Cα + 1 - ∆Cβ + 1) / 3. ∆δi values above 1 for three or
more consecutive residues are indicative of alpha helix (black) and below −1 of beta sheet secondary
structure, whereas ∆δi values between −1 and 1 indicate non-regular structure (white). (b,c) Cartoon
representation of BBA03 structure colored using rainbow color scheme. It starts with blue color at
N-terminus and gradually changes to red at C-terminus. In (c), the T-shaped pore identified by Mole
2.5 [11] online tool is shown in cyan. Clefts 1 and 2 found by CASTp software [12], larger than 20 Å3,
are denoted with numbers. The volume of the first cleft is 20.4 Å3 and of the second is – 76.8 Å3.
(d,e) Electrostatic potential of BBA03 surface, calculated using Adaptive Poisson-Boltzmann Solver
(APBS) Pymol plugin [13]. The gradient starts from red, where 5 kBT/e < 4, and moves to deep blue,
where 5 kBT/e > 4. Above mentioned clefts are marked with a dashed line.
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Table 1. Input data for BBA0353–169 structure calculation and structure quality statistics.
NOE upper distance limits 2602
Intra-residual (|i − j| = 0) 767
Sequential (|i − j| = 1) 626
Medium range (1 < |i − j| ≤ 4) 704
Long range (|i − j| ≥ 5) 616
Residual CYANA target function value after CNS (Å2) 9.75 ± 1.05
Residual NOE violations
Number ≥ 0.1 Å 29 ± 5
Maximum (Å) 0.38 ± 0.08
PARALLHDG force field energies (kcal/mol)
Total −5534 ± 101
Van der Waals −481 ± 19
Electrostatic −5961 ± 117
Root-mean-square-deviation (RMSD) from mean coordinates (residues 53–169) (Å)
Backbone 0.50 ± 0.06
All heavy atoms 0.90 ± 0.06
Molprobity structure statistics [14]
Ramachandran plot favored regions (%) 94.5
Ramachandran plot allowed regions (%) 99.3
Average clash score of all atoms and models 21.62 ± 2.47
NOE: nuclear Overhauser enhancement.Pathogens 2020, 9, x FOR PEER REVIEW 5 of 13 
 
 
Figure 2. Docking of fatty acids to BBA03. (a) List of fatty acids docked to the determined structure of 
BBA03 and their ligand efficiency. (b) Arachidic acid (yellow), arachidonic (green), and linoleic acid 
(magenta) docked to BBA03 (dark grey). Pore forming amino acid side chains (T52, L54, E55, L57, 
V58, R60, L61, L63, L71, T72, L74, T75, N76, L109, S110, I117, L120, and L121) are shown with thin 
lines and labeled. Side chains which form polar interactions with the fatty acids (R60 and N76) are 
colored blue, while other pore forming amino acids are colored in black. 
To test if BBA03 binds fatty acids, a 2D 1H-15N HSQC NMR spectrum was acquired after addition 
of 10 mM arachidonic acid, palmitic acid, linoleic acid, oleic acid, pelargonic acid, and steric acid to 1 
mM BBA03. However, the resulting spectra showed no chemical shift perturbations that would prove 
the binding of these molecules (Supplementary Figure S3). 
2.3. Structure Comparison 
A search of structurally similar proteins against Protein Data Bank (PDB) using Dali server [15] 
(Table 2) revealed that the closest structural homologue to BBA03 is Borrelia turicatae BTA121 (Figure 
3a). Strong similarity was observed with both polypeptide chains of BTA121 yielding Z-scores of 7.7 
and 7.4, and root-mean-square-deviations (RMSDs) of 2.3 Å  and 2.6 Å , respectively. BTA121 is 
encoded on the 150 kDa mega plasmid and, unlike BBA03, its expression is increased in the tick 
vector. Experiments in vitro have shown that BTA121 binds palmitic acid, but the binding site is 
unknown [16]. Analysis of BTA121 structure using Mole 2.5 [11] online tool found a similar T-shaped 
pore as in BBA03 (Figure 3b).  
A high structural similarity was observed also with BBP28, a B. burgdorferi mlp family outer 
surface lipoprotein (Figure 3c) [17]. The main difference between the structures of BBA03 and BBP28 
is the lack of the third α-helix in BBP28 and the replacement of the last α-helix in BBA03 with a highly 
variable extended loop in BBP28. Even though the structural similarity of BBA03 and BBP28 is lower 
than BTA121, the sequence similarity is substantially higher (see Table 2). 
Significant structural similarity is also observed with several Pfam54_60 proteins [18]: BBA64, 
BBA65, BBA66, BBA69, BGA71, BBA73, and CspA, all of which are α-helical (Figure 3d). Conserved 
amino acids among them are mostly hydrophobic and are located in the hydrophobic core of the 
protein, indicative of their function in structural conservation [18]. Thus, despite having a similar 
fold, Pfam54_60 members have diverse functions. For example, the fifth most similar protein to 
BBA03, CspA, binds complement factor H [19], while another Pfam54_60 member, BBA70, binds 
plasminogen [20]. 
Figure 2. Docking of fatty acids to BBA03. (a) List of fatty acids docked to the determined structure of
BBA03 and their li and efficiency. (b) rachidic acid (yellow), arachid nic (gr en), and linoleic acid
(magenta) docked to BBA03 (dark grey . Pore forming amino acid side chains (T52, L54, E55, L57, V58,
R60, L61, L63, L71, T72, L74, T75, N76, L109, S110, I117, L120, and L121) are shown with thin lines and
labeled. Side chains which form polar interactions with the fatty acids (R60 and N76) are colored blue,
while other por forming ami o acids are colored i bl k.
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To test if BBA03 binds fatty acids, a 2D 1H-15N HSQC NMR spectrum was acquired after addition
of 10 mM arachidonic acid, palmitic acid, linoleic acid, oleic acid, pelargonic acid, and steric acid to
1 mM BBA03. However, the resulting spectra showed no chemical shift perturbations that would prove
the binding of these molecules (Supplementary Figure S3).
2.3. Structure Comparison
A search of structurally similar proteins against Protein Data Bank (PDB) using Dali server [15]
(Table 2) revealed that the closest structural homologue to BBA03 is Borrelia turicatae BTA121 (Figure 3a).
Strong similarity was observed with both polypeptide chains of BTA121 yielding Z-scores of 7.7 and 7.4,
and root-mean-square-deviations (RMSDs) of 2.3 Å and 2.6 Å, respectively. BTA121 is encoded on the
150 kDa mega plasmid and, unlike BBA03, its expression is increased in the tick vector. Experiments
in vitro have shown that BTA121 binds palmitic acid, but the binding site is unknown [16]. Analysis of
BTA121 structure using Mole 2.5 [11] online tool found a similar T-shaped pore as in BBA03 (Figure 3b).Pathogens 2020, 9, x FOR PEER REVIEW 6 of 13 
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structures of BBA03 (cyan) and BTA121 (PDB: 5VJ4) (a,b), BBP28 (PDB: 6QBI) (c), BGA71 (PDB: 6FL0) 
(d). In (b) BTA121 is colored using rainbow color scheme. T-shaped pore in BTA121 identified by 
Mole 2.5 [11] online tool is shown in magenta. 
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Figure 3. Comparison of BBA03 i ra ly similar proteins found by Dali server. Su erposed
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(d). In (b) BTA121 is colored using rainbow color scheme. T-shaped pore in BTA121 identified by Mole
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A high structural similarity was observed also with BBP28, a B. burgdorferi mlp family outer
surface lipoprotein (Figure 3c) [17]. The main difference between the structures of BBA03 and BBP28 is
the lack of the third α-helix in BBP28 and the replacement of the last α-helix in BBA03 with a highly
variable extended loop in BBP28. Even though the structural similarity of BBA03 and BBP28 is lower
than BTA121, the sequence similarity is substantially higher (see Table 2).
Significant structural similarity is also observed with several Pfam54_60 proteins [18]: BBA64,
BBA65, BBA66, BBA69, BGA71, BBA73, and CspA, all of which are α-helical (Figure 3d). Conserved
amino acids among them are mostly hydrophobic and are located in the hydrophobic core of the
protein, indicative of their function in structural conservation [18]. Thus, despite having a similar
fold, Pfam54_60 members have diverse functions. For example, the fifth most similar protein to
BBA03, CspA, binds complement factor H [19], while another Pfam54_60 member, BBA70, binds
plasminogen [20].






BTA121 [16] 5VJ4 7.7 2.3 13 Binds fatty acids [16]
BBP28 [17] 6QBI 7.4 2.5 21 Unknown
BGA71 [21] 6FL0 7.0 2.9 12 Binds C7, C8 and C9 terminalcomplement components [19]
BBA69 [22] 6QO1 6.1 3.2 14 Unknown
CspA [23] 5A2U 6.1 3.3 11
Binds factor H and FHL-1 [24]
Binds C7 and C9 terminal
complement components [25]
BBE31 [26] 6FZE 5.4 3.1 9 Binds glutathione [26]
BBA64 [23] 4ALY 4.3 3.4 18 Unknown [9]
BBA65 [18] 4BG5 4.3 3.4 14 Unknown [27]
BBA66 [28] 2YN7 4.3 3.6 12 Unknown [29]
BBA73 [30] 4B2F 4.1 3.5 13 Unknown
2.4. Sequence Comparison
The sequence of BBA03 is well conserved among different genus Borrelia. Sequence alignment
with the five most structurally similar proteins identified in Table 2 shows that more than half of
the conserved amino acids are hydrophobic. Additionally, several positively charged amino acids
(R60, K68, K164) are highly conserved, although the positive charge on amino acids 60 and 164 is
conserved only in one chain of BTA121. Interestingly, although not all of the compared proteins contain
a T-shaped pore, the well conserved R60 residue is located in the positively charged cleft near the
entrance to the pore of BBA03. Overall, the highest conserved regions are found in helices α1-α4 as
well as the N-terminal parts of α5 and α6 (Figure 4).
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Figure 4. Sequence comparison of BBA03 with structured parts of five structurally most similar 
proteins from Borrelia genus: BTA121 (GenBank: YP_009164930.1), BBP28 (GenBank: 
WP_010883731.1), BGA71 (GenBank: WP_011187214.1), BBA69 (AAC66287), and CspA (AAC66286). 
[31]. Both polypeptide chains of BTA121 (A and B) are shown in the alignment. BBA03 secondary 
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Figure 4. Sequence comparison of BBA03 with structured parts of five structurally most similar proteins
from Borrelia genus: BTA121 (GenBank: YP_009164930.1), BBP28 (GenBank: WP_010883731.1), BGA71
(GenBank: WP_011187214.1), BBA69 (AAC66287), and CspA (AAC66286). [31]. Both polypeptide
chains of BTA121 (A and B) are shown in the alignment. BBA03 secondary structure elements and
residue numbering are indicated above the alignment. Residues that are conserved or the same type
as in BBA03 are highlighted in blue (A, I, L, M, F, W and V), turquoise (Y and H), green (N, Q, S and
T), red (R and K), purple (D and E), orange (G), pink (C) and yellow (P). Lighter coloring indicates
lower similarity.
3. Discussion
B. burgdorferi outer surface lipoproteins are the most easily accessible antigenic proteins to mammal
immune system during infection. For this reason, they are the primary targets for development of
vaccines against Lyme disease. In this work, the solution structure of B. burgdorferi outer surface
lipoprotein BBA03 was determined revealing a fold with seven α-helices most similar to that of
Borrelia turicatae BTA121, which has been shown to bind palmitic acid. Remarkably, both protein
structures feature two clefts on their surface, which are connected through a long T-shaped hydrophobic
pore that could possibly bind lipids. Docking of fatty acids into BBA03 showed that presence of
double bonds and increased fatty acid chain length improves ligand binding efficiency. Four fatty
acids with the highest binding efficiency were found to dock in the region of the hydrophobic pore,
forming hydrophobic contacts as well as polar contacts between the carboxylic group and the surface
exposed residues. NMR titration experiments showed no interaction between BBA03 and linoleic acid,
oleic acid, arachidonic acid, pelargonic acid, palmitic acid, or steric acid. This does not exclude the
possibility of another fatty acid or hydrophobic molecule binding to BBA03.
Another class of structurally similar proteins to BBA03 are the members of Pfam54_60, which have
gained their name from their location on the lp54 plasmid [9,19,21–25,27,28,30]. Despite having high
structural similarity, the sequence similarity among Pfam54_60 members is rather low, averaging to
around 18%, which has resulted in high functional diversity [18]. The mlp family member BBP28 also
has a high structural similarity to BBA03, but it is located on φBB-1 prophage cp32-1 plasmid [32,33].
The overall fold conservation among proteins without functional relevance is a result of major genetic
variations and recombinations in the Borrelia genome, which has produced a large number of paralogue
gene families [5]. One such variation is the insertion of the cp32 plasmid into the lp54 precursor,
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which probably resulted in formation of BBA03. Due to the high structural similarity of functionally
divergent lipoproteins in B. burgdorferi, determination of function is rarely possible by mere structural
comparison. The task is even further complicated by lack of sequence homologues among other
bacteria [32,34].
To our knowledge, BBA03 is the only protein that plays an important role during tick transmission
that is manifested only when B. burgdorferi is in a mixed infection with other spirochetes in the tick
body [8]. A similar phenotype is displayed by BBA07, BBA64, and BBA66, which are located on lp54
and have an unknown function. Borrelia lacking these proteins have shown attenuation of infection
by tick vector [8,9,29,35], whereas ability of Borrelia to infect mammals through a needle inoculation
was not affected, similarly as in the case of BBA03 [36,37]. Furthermore, neither the ∆BBA01–07
nor the ∆BBA64 deletion affected the Borrelia transition from tick midgut to salivary glands [8,9,35],
indicating that BBA03, BBA07, and BBA64 all perform their respective functions in the period of
transition from tick vector to mammal host. Such overlap of phenotype indicates a possibility that
these proteins have similar or connected functions. This hypothesis is even furthered by the fact that,
due to high genetic recombination rate, the functions of Borrelia OSPs often tend to overlap [7,38].
Besides providing a competitive advantage to Borrelia burgdorferi, the deletion of BBA03 slows
down their colony growth rate, and the colonies grown are more diffuse [8]. As BBA03 is an outer
surface lipoprotein, which does not form homodimers, this finding indicates that it either interacts with
a compound in the medium or with another molecule on the surface of Borrelia. Research investigating
BBA03 effect on colony growth used BSKII medium, which contains a fatty acid source such as 6% rabbit
serum. Therefore, the hypothesis that BBA03 binds fatty acids would be in consistence with this finding.
Proteins with such function are necessary for B. burgdorgferi, as they lack the enzymes necessary for
cholesterol and other fatty acid biosynthesis or elongation [39,40]. To the authors’ knowledge, there are
no known fatty acid binding B. burgdorferi lipoproteins. Furthermore, complex fatty acids gained
from the environment do play an important role in the formation of complex lipid rafts structures
found on the surface of Borrelia [41,42]. Previous research in fact shows that B. burgdorferi do exchange
cholesterol with mammal cells through vesicles and direct contact [43].
In conclusion, we determined the solution NMR structure of BBA03, a Borrelia burgdorferi
competitive advantage promoting outer surface lipoprotein. On its surface, a T-shaped hydrophobic
pore was found, which could bind lipids. Although docking experiments suggested possible binding
of long-chain fatty acids in the pore, NMR titration experiments were performed but showed no
interaction. Based on our findings, we hypothesize that BBA03 confers competitive advantage to
Borrelia by enhancing the fitness of the bacteria. Future binding studies with the components of BSKII
medium or additional lipid molecules need to be performed in order to determine the exact function
of BBA03.
4. Materials and Methods
4.1. Protein Sample Preparation
BBA03 was produced from pETm-11 plasmid [44], omitting the first 22 residues encoding the signal
sequence. Constructs comprising residues 23–169 (with tether region) and 53–169 (only structured
region) were used for protein backbone resonance assignment and structure determination, respectively.
The second construct containing only the structured part was obtained by amplifying the part
excluding the N-terminal tether region and ligating back into the pETm-11 vector using the primers
5′- ataccatgggtacacctttagaaaaattagt -3′ and 5′- cagcctcgagctatatagtgtctttaagtttat -3′, where the NcoI
and the XhoI restriction sites were underlined. The obtained plasmid was used in BL21DE3 E. coli
cell transformation, and the doubly labeled proteins were expressed in M9 minimal media containing
2g/l [13C6]-d-glucose and 1 g/l 15NH4Cl (Cambridge Isotope Laboratories) as sole sources of carbon
and nitrogen, respectively. The cells were grown at 37 ◦C in the presence of 50 mg/l kanamycin
and induced when absorbance at 600 nm (OD600) reached ~0.6. After 4 h of expression, E. coli were
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harvested at 10000 g, 4 ◦C for 10 min and frozen at −20 ◦C. The cell pellets were resuspended in 40 mL
buffer A (20 mM sodium phosphate, pH 7.5, 300 mM NaCl, 15 mM imidazole) and were lysed by
ultrasonication. Soluble cell lysate fraction was separated by centrifugation for 40 min at 25,000× g,
4 ◦C and filtration thorough a 0.22 µm pore-sized filter. The solution was loaded onto a 5 mL HisTrap
HP column (GE Helthcare). The bound protein was eluted using imidazole gradient from 15 to 300 mM
over 30 mL volume. Fractions containing BBA03 were concentrated to 1 mL using ultra-centrifugal
filter units with 10 kDa molecular weight cutoff. To remove N-terminal His-tag, 25 µg/mL of tobacco
etch virus (TEV) protease were added, and the solution was kept overnight at 4 ◦C. Afterwards, it
was passed through a HisTrap HP column and concentrated to 550 µL in NMR buffer (20 mM sodium
phosphate, pH 6.8, 50 mM NaCl). Each purification step was monitored by SDS-PAGE.
NMR samples were prepared by adding 5% (v/v) D2O and 0.03% NaN3 to a 1.5 to 2 mM
13C,15N-labeled BBA03 solution. For lipid binding experiments, 10 mM fatty acids were added to
the NMR sample tube containing 1 mM protein and mixed thoroughly before performing NMR
measurements. Palmitic acid was dissolved in 30 µL of ethanol before addition to the sample
(final concentration of ethanol in the sample was 5%).
4.2. NMR Spectroscopy
NMR experiments were conducted at 298 K on a Varian Unity Inova 600 MHz
spectrometer equipped with a TCI HCN z-gradient cryoprobe or Bruker Avance III
HD 800 MHz spectrometer equipped with an TXI z-gradient room temperature probe.
For backbone assignment, 3D HNCA, 3D HNCO, 3D CBCA(CO)HN, and 3D HN(CA)CO
spectra were acquired. 3D [1H,1H]-NOESY-15N-HSQC, 3D [1H,1H]-NOESY-13C(aliphatic)-HSQC,
3D [1H,1H]-NOESY-13C(aromatic)-HSQC spectra were acquired using a mixing time of 80 ms.
Chemical shifts were referenced internally to the residual water signal at 4.77 ppm relative to
4,4-dimethyl-4-silapentane-1-sulfonic acid (DSS).
4.3. NMR Relaxation Data
Residue-specific protein backbone amide 15N NMR R1 and R2 relaxation times were calculated from
peak intensities in 15N-T1 and 15N-T2 (gNT1T2) relaxation spectra using two-parameter exponential fit
model in relax 4.0.3 [45]. Nine T1 (10 to 1500 ms) and seven T2 (10 to 210 ms) delays were used for
the recording of the decay curves. Protein rotational correlation time (τc) was calculated using the
following equation: τc ≈ 14 πvN
√
6 T1T2 − 7 [46], where νN is the
15N resonance frequency (in Hz), T1 is
average longitudinal, and T2 is average transverse relaxation time value of rigid protein regions.
4.4. NMR Structure Determination
Spectra were processed using TopSpin 3.5pl7 software. Chemical shifts of protein backbone and
side chain nuclei were assigned by analysis of all the acquired spectra in CARA [47]. NOE upper
distance limits were automatically obtained from UNIO ATNOS/CANDID 2.0.2 [48–50], which was
used together with NMR structure calculation algorithm CYANA 2.1 [51]. Seven cycles of UNIO
ATNOS/CANDID protocol were used, starting with 100 random conformers that were subjected to
simulated-annealing with 10,000 steps of torsion-angle molecular dynamics. The 25 conformers with
the lowest residual CYANA target-function values after UNIO ATNOS/CANDID cycle 7 were energy
minimized in explicit water using CNS [52]. The coordinates of the final 20 NMR conformers and all
restraints were deposited in the Protein Data Bank (accession code 6QS0), and chemical shifts were
deposited in BMRB (accession code 34361).
4.5. Molecular Docking
The solution NMR structure of B. burgdorferi outer surface lipoprotein BBA03 determined in
this study was prepared for docking using the protein preparation wizard tool in Maestro 12.4 [53].
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Fatty acids (C10 to C20 saturated fatty acids, as well as arachidonic, linoleic, and oleic acids) were
prepared for docking using the standard protocol implemented in LigPrep.
Docking was performed using the Induced Fit Docking tool implemented in Maestro Schrodinger
software. Centroid of Leu27, Leu73, and Leu74 was selected as a docking box center. Docking box
length was set to 30 Å. Protein and ligand van der Waals radius scaling was set to 0.5. Up to 20 poses
per ligand were retained after the initial docking and were further minimized by refining the protein
residues within 5.0 Å from the ligand. OPLS3e force field [54] was used for the complex minimization.
Docking scores were calculated by re-docking ligands in the top 5 optimized proteins structures at a
standard precision using Glide. Ligand efficiency was calculated as docking score per ligand heavy
atom count.
Supplementary Materials: The following are available online at http://www.mdpi.com/2076-0817/9/10/826/s1,
Figure S1: Graphic of globular protein MW/ τc ratio. Points from reference proteins [55] are colored in black,
and the experimentally determined τc value/MW of BBA03 calculated from the trendline equation is shown in red.
Figure S2: Assigned 2D 15N-1H HSQC NMR spectrum of BBA03. Backbone amide (black labels) and side chain
peaks (grey labels) are labeled with one-letter amino acid codes and numbered as in Uniport database (Q44849).
Amino acid residues remaining from the expression vector after TEV cleavage (red labels) are numbered with
negative sequence numbers. Figure S3: NMR analysis of BBA03 binding with fatty acids. 2D 15N-1H HSQC NMR
spectra of 1 mM BBA03 in 20 mM sodium phosphate, pH 6.8, 50 mM NaCl solution in absence (blue) and presence
(red) of 10 mM linoleic acid (a), pelargonic acid (b), oleic acid (c), arachidonic acid (d), steric acid (e), and palmitic
acid (f). In panels (c) and (f), the solution additionally contains respectively 9% and 5% EtOH.
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supervision, K.J. All authors have read and agreed to the published version of the manuscript.
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